Pharmedium Recalls Fentanyl Citrate Syringes Due to Stability Data Concerns
Pharmedium Services, LLC is recalling 616 syringes of fentanyl citrate because stability data does not support the expiry dates, posing a risk of loss of potency.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that might cause temporary or medically reversible adverse health consequences. The specific hazard is a potential loss of potency due to stability data issues, which is a quality defect rather than a direct physical injury or contamination risk.
Plain-English summary
Pharmedium Services, LLC is recalling 616 syringes of fentanyl citrate, 10 mcg per mL (25 mcg per 2.5 mL), in 0.9% Sodium Chloride, 2.5 mL Total Volume in a syringe, For IV Use. The product is identified by Product code 2R3424 and is distributed nationwide.
The recall was initiated because stability data does not support the expiry dates for the drugs packaged and stored in syringes. This condition creates a potential for loss of potency in the medication.
The affected lot numbers are 15103031M, 15127041M, 15139034M, 15140039M, 15141048M, 15147057M, 15147086M, 15148053M, and 151880285M. These lots have expiration dates between 07/15/15 and 10/12/15. Healthcare providers and patients should stop using the affected product and contact Pharmedium Services, LLC for further instructions.
The recalled product
- Product
- fentaNYL Citrate, 10 mcg per mL (25 mcg per 2.5 mL), in 0.9% Sodium Chloride, 2.5 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3424.
- Manufacturer
- Pharmedium Services, LLC
- Category
- Drug — Injectable Medication
- Affected units
- 616
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot Numbers: 15103031M
- 15127041M
- 15139034M
- 15140039M
- 15141048M
- 15147057M
- 15147086M
- 15148053M
- 151880285M
- Exp between 07/15/15-10/12/15
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 69 recalled by Pharmedium Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 69 products in this recall →Related recalls
Same manufacturer · Pharmedium Services, LLC
See all →- SeverePharMEDium Recalls ePHEDrine Sulfate Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls nICARdipine HCl Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
Same hazard · loss of potency
See all →- ModerateInfuvite Adult Multiple Vitamins Injection Recalled Due to Cold Chain Failure
FDA (Drugs) · 2025-05-07
- ModerateCardinal Health Recalls Cyanocobalamin Injection Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateSmiths Medical Recalls Arterial Blood Sampling Kits with Povidone Iodine Pads
FDA (Devices) · 2019-02-27
- ModerateBiomerieux Recalls VITEK 2 Gram Negative Susceptibility Cards Due to Moisture Risk
FDA (Devices) · 2017-06-21
- ModerateBiomerieux Recalls VITEK 2 Gram Negative Susceptibility Cards
FDA (Devices) · 2017-06-21